Skip to main content
Erschienen in: Heart Failure Reviews 2/2018

31.01.2018

The dark side of the kidney in cardio-renal syndrome: renal venous hypertension and congestive kidney failure

verfasst von: Pierpaolo Di Nicolò

Erschienen in: Heart Failure Reviews | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Renal involvement in some forms of acute or chronic diseases, such as heart failure or sepsis, presents with a complex pathophysiological basis that is not always clearly distinguishable. In these clinical settings, kidney failure is traditionally and almost exclusively attributed to renal hypoperfusion and it is commonly accepted that causal elements are pre-renal, such as a reduction in the ejection fraction or absolute or relative hypovolemia acting directly on oxygen transport mechanisms and renal autoregulation systems, causing a reduction of glomerular filtration rate. Nevertheless, the concept emerging from accumulating clinical and experimental evidence is that in complex clinical pictures, kidney failure is strongly linked to the hemodynamic alterations occurring in the renal venous micro and macrocirculation. Accordingly, the transmission of the increased venous pressure to the renal venous compartment and the consequent increasing renal afterload has a pivotal role in determining and sustaining the kidney damage. The aim of this review was to clarify the physiopathological aspects of the link between worsening renal function and renal venous hypertension, analyzing the prognostic and therapeutic implications of the so-called congestive kidney failure in cardio-renal syndrome and in other clinical contexts of its possible onset.
Literatur
2.
Zurück zum Zitat Fiksen-Olsen MJ, Strick DM, Hawley H, Romero JC (1992) Renal effects of angiotensin II inhibition during increases in renal venous pressure. Hypertension 19(2 Suppl):II 137–II 141 Fiksen-Olsen MJ, Strick DM, Hawley H, Romero JC (1992) Renal effects of angiotensin II inhibition during increases in renal venous pressure. Hypertension 19(2 Suppl):II 137–II 141
4.
Zurück zum Zitat Sui F, Zheng Y, Li WX, Zhou JL (2016) Renal circulation and microcirculation during intra-abdominal hypertension in a porcine model. Eur Rev Med Pharmacol Sci 20(3):452–461PubMed Sui F, Zheng Y, Li WX, Zhou JL (2016) Renal circulation and microcirculation during intra-abdominal hypertension in a porcine model. Eur Rev Med Pharmacol Sci 20(3):452–461PubMed
5.
Zurück zum Zitat Mason J, Welsch J, Torhorst J (1987) The contribution of vascular obstruction to the functional defect that follows renal ischemia. Kidney Int 31(1):65–71CrossRefPubMed Mason J, Welsch J, Torhorst J (1987) The contribution of vascular obstruction to the functional defect that follows renal ischemia. Kidney Int 31(1):65–71CrossRefPubMed
6.
Zurück zum Zitat Firth JD, Raine AE, Ledingham JG (1988) Raised venous pressure: a direct cause of renal sodium retention in oedema? Lancet 1(8593):1033–1035CrossRefPubMed Firth JD, Raine AE, Ledingham JG (1988) Raised venous pressure: a direct cause of renal sodium retention in oedema? Lancet 1(8593):1033–1035CrossRefPubMed
8.
Zurück zum Zitat Wathen RL, Selkurt EE (1969) Intrarenal regulatory factors of salt excretion during renal venous pressure elevation. Am J Phys 216:1517–1524 Wathen RL, Selkurt EE (1969) Intrarenal regulatory factors of salt excretion during renal venous pressure elevation. Am J Phys 216:1517–1524
9.
Zurück zum Zitat Burnett JC, Haas JA, Knox FG (1982) Segmental analysis of sodium reabsorption during renal vein constriction. Am J Phys 243(1):F19–F22 Burnett JC, Haas JA, Knox FG (1982) Segmental analysis of sodium reabsorption during renal vein constriction. Am J Phys 243(1):F19–F22
11.
Zurück zum Zitat Granger JP (1986) Regulation of sodium excretion by renal interstitial hydrostatic pressure. Fed Proc 45:2892–2289PubMed Granger JP (1986) Regulation of sodium excretion by renal interstitial hydrostatic pressure. Fed Proc 45:2892–2289PubMed
13.
Zurück zum Zitat Charkoudian N, Martin EA, Dinenno FA, Eisenach JH, Dietz NM, Joyner MJ (2004) Influence of increased central venous pressure on baroreflex control of sympathetic activity in humans. Am J Physiol Heart Circ Physiol 287:1658–1662CrossRef Charkoudian N, Martin EA, Dinenno FA, Eisenach JH, Dietz NM, Joyner MJ (2004) Influence of increased central venous pressure on baroreflex control of sympathetic activity in humans. Am J Physiol Heart Circ Physiol 287:1658–1662CrossRef
15.
Zurück zum Zitat Sosa RE, Volpe M, Marion DN, Atlas SA, Laragh JH, Vaughan ED Jr, Maack T (1986) Relationship between renal hemodynamic and natriuretic effects of atrial natriuretic factor. Am J Phys 250(3 Pt 2):F520–F524 Sosa RE, Volpe M, Marion DN, Atlas SA, Laragh JH, Vaughan ED Jr, Maack T (1986) Relationship between renal hemodynamic and natriuretic effects of atrial natriuretic factor. Am J Phys 250(3 Pt 2):F520–F524
16.
Zurück zum Zitat Rokitansky AM, Losert UM, Trubel W, Wieselthaler G, Krausler S, Shreiner W, Buxbaum P, Vierhapper H, Waldhäusl WK, Wolner E (1990) Action of endogenous atrial natriuretic peptide in calves with experimental acute central venous congestion and low cardiac output. Cardiovasc Res 24(5):345–351. https://doi.org/10.1093/cvr/24.5.345 CrossRefPubMed Rokitansky AM, Losert UM, Trubel W, Wieselthaler G, Krausler S, Shreiner W, Buxbaum P, Vierhapper H, Waldhäusl WK, Wolner E (1990) Action of endogenous atrial natriuretic peptide in calves with experimental acute central venous congestion and low cardiac output. Cardiovasc Res 24(5):345–351. https://​doi.​org/​10.​1093/​cvr/​24.​5.​345 CrossRefPubMed
17.
Zurück zum Zitat Gopi V, Parthasarathy A, Umadevi S, Vellaichamy E (2013) Angiotensin-II down-regulates cardiac natriuretic peptide receptor—a mediated anti-hypertrophic signaling in experimental rat hearts. Indian J Exp Biol 51(1):48–55PubMed Gopi V, Parthasarathy A, Umadevi S, Vellaichamy E (2013) Angiotensin-II down-regulates cardiac natriuretic peptide receptor—a mediated anti-hypertrophic signaling in experimental rat hearts. Indian J Exp Biol 51(1):48–55PubMed
18.
Zurück zum Zitat Volpe M, Carnovali M, Mastromarino V (2016) The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment. Clin Sci (Lond) 130(2):57–77CrossRef Volpe M, Carnovali M, Mastromarino V (2016) The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment. Clin Sci (Lond) 130(2):57–77CrossRef
27.
Zurück zum Zitat Van den Berg BM, Vink H, Spaan JA (2003) The endothelial glycocalyx protects against myocardial edema. Circ Res 92:592–594CrossRefPubMed Van den Berg BM, Vink H, Spaan JA (2003) The endothelial glycocalyx protects against myocardial edema. Circ Res 92:592–594CrossRefPubMed
28.
Zurück zum Zitat Berg S, Golster M, Lisander B (2002) Albumin extravasation and tissue washout of hyaluronan after plasma volume expansion with crystalloid or hypooncotic colloid solutions. Acta Anaesthesiol Scand 46:166–172CrossRefPubMed Berg S, Golster M, Lisander B (2002) Albumin extravasation and tissue washout of hyaluronan after plasma volume expansion with crystalloid or hypooncotic colloid solutions. Acta Anaesthesiol Scand 46:166–172CrossRefPubMed
29.
Zurück zum Zitat Jünger M, Steins A, Hahn M, Häfner HM (2000) Microcirculatory dysfunction in chronic venous insufficiency (CVI). Microcirculation 7(6 Pt 2):S3–12CrossRefPubMed Jünger M, Steins A, Hahn M, Häfner HM (2000) Microcirculatory dysfunction in chronic venous insufficiency (CVI). Microcirculation 7(6 Pt 2):S3–12CrossRefPubMed
32.
Zurück zum Zitat Colombo PC, Rastogi S, Onat D et al (2009) Activation of endothelial cells in conduit veins of dogs with heart failure and veins of normal dogs after vascular stretch by acute volume loading. J Card Fail 15:457–463CrossRefPubMedPubMedCentral Colombo PC, Rastogi S, Onat D et al (2009) Activation of endothelial cells in conduit veins of dogs with heart failure and veins of normal dogs after vascular stretch by acute volume loading. J Card Fail 15:457–463CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Damman K, Jaarsma T, Voors AA, Navis G, Hillege HL, van Veldhuisen DJ, COACH investigators (2009) Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the coordinating study evaluating outcome of advising and counseling in heart failure (COACH). Eur J Heart Fail 11(9):847–854. https://doi.org/10.1093/eurjhf/hfp108 CrossRefPubMed Damman K, Jaarsma T, Voors AA, Navis G, Hillege HL, van Veldhuisen DJ, COACH investigators (2009) Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the coordinating study evaluating outcome of advising and counseling in heart failure (COACH). Eur J Heart Fail 11(9):847–854. https://​doi.​org/​10.​1093/​eurjhf/​hfp108 CrossRefPubMed
37.
Zurück zum Zitat Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53(7):589–596CrossRefPubMedPubMedCentral Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53(7):589–596CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Kos T, Pacher R, Wimmer A et al (1998) Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure. Wien Klin Wochenschr 110:89–95PubMed Kos T, Pacher R, Wimmer A et al (1998) Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure. Wien Klin Wochenschr 110:89–95PubMed
40.
42.
Zurück zum Zitat Forrester JS, Diamond G, Chatterjee K, Swan HJ (1976) Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts). N Engl J Med 295(24):1356–1362CrossRefPubMed Forrester JS, Diamond G, Chatterjee K, Swan HJ (1976) Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts). N Engl J Med 295(24):1356–1362CrossRefPubMed
48.
Zurück zum Zitat Binanay C, Califf RM, Hasselblad V, O’Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW, ESCAPE Investigators and ESCAPE Study Coordinators (2005) Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294(13):1625–1633. https://doi.org/10.1001/jama.294.13.1625 CrossRefPubMed Binanay C, Califf RM, Hasselblad V, O’Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW, ESCAPE Investigators and ESCAPE Study Coordinators (2005) Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294(13):1625–1633. https://​doi.​org/​10.​1001/​jama.​294.​13.​1625 CrossRefPubMed
49.
Zurück zum Zitat Nohria A, Hasselblad V, Stebbins A et al (2008) Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 51:1268–1274CrossRefPubMed Nohria A, Hasselblad V, Stebbins A et al (2008) Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol 51:1268–1274CrossRefPubMed
50.
Zurück zum Zitat Hanberg JS, Sury K, Wilson FP et al (2016) Reduced cardiac index is not the dominant driver of renal dysfunction in heart failure. J Am Coll Cardiol 67:2199–2208CrossRefPubMedPubMedCentral Hanberg JS, Sury K, Wilson FP et al (2016) Reduced cardiac index is not the dominant driver of renal dysfunction in heart failure. J Am Coll Cardiol 67:2199–2208CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Kirkpatrick AW, Roberts DJ, De Waele J, Jaeschke R, Malbrain ML, De Keulenaer B, Duchesne J, Bjorck M, Leppaniemi A, Ejike JC, Sugrue M, Cheatham M, Ivatury R, Ball CG, Reintam Blaser A, Regli A, Balogh ZJ, D’Amours S, Debergh D, Kaplan M, Kimball E, Olvera C, Pediatric Guidelines Sub-Committee for the World Society of the Abdominal Compartment Syndrome (2013) Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med 39(7):1190–1206CrossRefPubMedPubMedCentral Kirkpatrick AW, Roberts DJ, De Waele J, Jaeschke R, Malbrain ML, De Keulenaer B, Duchesne J, Bjorck M, Leppaniemi A, Ejike JC, Sugrue M, Cheatham M, Ivatury R, Ball CG, Reintam Blaser A, Regli A, Balogh ZJ, D’Amours S, Debergh D, Kaplan M, Kimball E, Olvera C, Pediatric Guidelines Sub-Committee for the World Society of the Abdominal Compartment Syndrome (2013) Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med 39(7):1190–1206CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Mohmand H, Goldfarb SJ (2011) Renal dysfunction associated with intra-abdominal hypertension and the abdominal compartment syndrome. J Am Soc Nephrol 22(4):615–621CrossRefPubMed Mohmand H, Goldfarb SJ (2011) Renal dysfunction associated with intra-abdominal hypertension and the abdominal compartment syndrome. J Am Soc Nephrol 22(4):615–621CrossRefPubMed
61.
Zurück zum Zitat Luca A, Feu F, García-Pagán JC, Jiménez W, Arroyo V, Bosch J, Rodés JH (1994) Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites. Hepatology 20(1 Pt 1):30–33PubMed Luca A, Feu F, García-Pagán JC, Jiménez W, Arroyo V, Bosch J, Rodés JH (1994) Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites. Hepatology 20(1 Pt 1):30–33PubMed
64.
Zurück zum Zitat Felker GM, Mentz RJ (2012) Diuretics and ultrafiltration in acute decompensated heart failure. J Am Coll Cardiol 59:2145e53CrossRef Felker GM, Mentz RJ (2012) Diuretics and ultrafiltration in acute decompensated heart failure. J Am Coll Cardiol 59:2145e53CrossRef
68.
Zurück zum Zitat Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN (1985) Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med 103(1):1–6CrossRefPubMed Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN (1985) Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med 103(1):1–6CrossRefPubMed
71.
Zurück zum Zitat Felker GM, Lee KL, Bull DA, Redield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Oili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O’Connor CM (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364(9):797–805. https://doi.org/10.1056/NEJMoa1005419 CrossRefPubMedPubMedCentral Felker GM, Lee KL, Bull DA, Redield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Oili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O’Connor CM (2011) Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 364(9):797–805. https://​doi.​org/​10.​1056/​NEJMoa1005419 CrossRefPubMedPubMedCentral
73.
Zurück zum Zitat Thalhammer C, Aschwanden M, Odermatt A, Baumann UA, Imfeld S, Bilecen D, Marsch SC, Jaeger KA (2007) Noninvasive central venous pressure measurement by controlled compression sonography at the forearm. J Am Coll Cardiol 50(16):1584–1589CrossRefPubMed Thalhammer C, Aschwanden M, Odermatt A, Baumann UA, Imfeld S, Bilecen D, Marsch SC, Jaeger KA (2007) Noninvasive central venous pressure measurement by controlled compression sonography at the forearm. J Am Coll Cardiol 50(16):1584–1589CrossRefPubMed
76.
Zurück zum Zitat Bart BA, Boyle A, Bank AJ et al (2005) Ultrafiltration versus usual care for hospitalized patients with heart failure: the relief for acutely fluid overloaded patients with decompensated congestive heart failure (RAPID-CHF) trial. J Am Coll Cardiol 46:2043–2046CrossRefPubMed Bart BA, Boyle A, Bank AJ et al (2005) Ultrafiltration versus usual care for hospitalized patients with heart failure: the relief for acutely fluid overloaded patients with decompensated congestive heart failure (RAPID-CHF) trial. J Am Coll Cardiol 46:2043–2046CrossRefPubMed
77.
Zurück zum Zitat Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA, UNLOAD Trial Investigators (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49(6):675–683. https://doi.org/10.1016/j.jacc.2006.07.073 CrossRefPubMed Costanzo MR, Guglin ME, Saltzberg MT, Jessup ML, Bart BA, Teerlink JR, Jaski BE, Fang JC, Feller ED, Haas GJ, Anderson AS, Schollmeyer MP, Sobotka PA, UNLOAD Trial Investigators (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49(6):675–683. https://​doi.​org/​10.​1016/​j.​jacc.​2006.​07.​073 CrossRefPubMed
80.
81.
Zurück zum Zitat Kazory A (2016) Ultrafiltration therapy for heart failure: balancing likely benefits against possible risks. Clin J Am Soc Nephrol 11(8):1463–1471CrossRefPubMedPubMedCentral Kazory A (2016) Ultrafiltration therapy for heart failure: balancing likely benefits against possible risks. Clin J Am Soc Nephrol 11(8):1463–1471CrossRefPubMedPubMedCentral
85.
Zurück zum Zitat Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF Jr, Dorobantu MI, Grinfeld LR, Jondeau G, Marmor A, Masip J, Pang PS, Werdan K, Teichman SL, Trapani A, Bush CA, Saini R, Schumacher C, Severin TM, Metra M (2013) Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX AHF): a randomised, placebo-controlled trial. Lancet 381(9860):29–39. https://doi.org/10.1016/S0140-6736(12)61855-8 CrossRefPubMed Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF Jr, Dorobantu MI, Grinfeld LR, Jondeau G, Marmor A, Masip J, Pang PS, Werdan K, Teichman SL, Trapani A, Bush CA, Saini R, Schumacher C, Severin TM, Metra M (2013) Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX AHF): a randomised, placebo-controlled trial. Lancet 381(9860):29–39. https://​doi.​org/​10.​1016/​S0140-6736(12)61855-8 CrossRefPubMed
86.
Zurück zum Zitat Metra M, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF Jr, Dorobantu MI, Grinfeld L, Jondeau G, Marmor A, Masip J, Pang PS, Werdan K, Prescott MF, Edwards C, Teichman SL, Trapani A, Bush CA, Saini R, Schumacher C, Severin T, Teerlink JR, Investigators RELAX-AHF (2013) Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the relaxin in acute heart failure (RELAX-AHF) development program: correlation with outcomes. J Am Coll Cardiol 61(2):196–206. https://doi.org/10.1016/j.jacc.2012.11.005 CrossRefPubMed Metra M, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Ponikowski P, Unemori E, Voors AA, Adams KF Jr, Dorobantu MI, Grinfeld L, Jondeau G, Marmor A, Masip J, Pang PS, Werdan K, Prescott MF, Edwards C, Teichman SL, Trapani A, Bush CA, Saini R, Schumacher C, Severin T, Teerlink JR, Investigators RELAX-AHF (2013) Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the relaxin in acute heart failure (RELAX-AHF) development program: correlation with outcomes. J Am Coll Cardiol 61(2):196–206. https://​doi.​org/​10.​1016/​j.​jacc.​2012.​11.​005 CrossRefPubMed
88.
Zurück zum Zitat Witteles RM, Kao D, Christopherson D, Matsuda K, Vagelos RH, Schreiber D, Fowler MB (2007) Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction: a randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 50(19):1835–1840. https://doi.org/10.1016/j.jacc.2007.03.071 CrossRefPubMed Witteles RM, Kao D, Christopherson D, Matsuda K, Vagelos RH, Schreiber D, Fowler MB (2007) Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction: a randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol 50(19):1835–1840. https://​doi.​org/​10.​1016/​j.​jacc.​2007.​03.​071 CrossRefPubMed
90.
Zurück zum Zitat Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O’Meara E, Tang WH, Starling RC, Butler J, Deswal A, Felker GM, O’Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Mann DL, Dávila-Román VG, McNulty SE, Borlaug BA, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM (2013) Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA 310(23):2533–2543. https://doi.org/10.1001/jama.2013.282190 CrossRefPubMedPubMedCentral Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O’Meara E, Tang WH, Starling RC, Butler J, Deswal A, Felker GM, O’Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Mann DL, Dávila-Román VG, McNulty SE, Borlaug BA, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM (2013) Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA 310(23):2533–2543. https://​doi.​org/​10.​1001/​jama.​2013.​282190 CrossRefPubMedPubMedCentral
93.
Zurück zum Zitat JJ MM, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, PARADIGM-HF Investigators and Committees (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371(11):993–1004. https://doi.org/10.1056/NEJMoa1409077 CrossRef JJ MM, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, PARADIGM-HF Investigators and Committees (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371(11):993–1004. https://​doi.​org/​10.​1056/​NEJMoa1409077 CrossRef
96.
Zurück zum Zitat Damman K, Voors AA (2007) Levosimenda improves renal function in acute decompensated heart failure: cause and clinicalapplication. Editorial to: “Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine by Yilmaz et al.”. Cardiovasc Drugs Ther 21(6):403–404CrossRefPubMed Damman K, Voors AA (2007) Levosimenda improves renal function in acute decompensated heart failure: cause and clinicalapplication. Editorial to: “Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine by Yilmaz et al.”. Cardiovasc Drugs Ther 21(6):403–404CrossRefPubMed
99.
Zurück zum Zitat Cholley B, Caruba T, Grosjean S, Amour J, Ouattara A, Villacorta J, Miguet B, Guinet P, Lévy F, Squara P, Aït Hamou N, Carillon A, Boyer J, Boughenou MF, Rosier S et al (2017) Effect of Levosimendan on low cardiac output syndrome in patients with low ejection fraction undergoing coronary artery bypass grafting with cardiopulmonary bypass: the LICORN randomized clinical trial. JAMA 318(6):548–556. https://doi.org/10.1001/jama.2017.9973 CrossRefPubMedPubMedCentral Cholley B, Caruba T, Grosjean S, Amour J, Ouattara A, Villacorta J, Miguet B, Guinet P, Lévy F, Squara P, Aït Hamou N, Carillon A, Boyer J, Boughenou MF, Rosier S et al (2017) Effect of Levosimendan on low cardiac output syndrome in patients with low ejection fraction undergoing coronary artery bypass grafting with cardiopulmonary bypass: the LICORN randomized clinical trial. JAMA 318(6):548–556. https://​doi.​org/​10.​1001/​jama.​2017.​9973 CrossRefPubMedPubMedCentral
Metadaten
Titel
The dark side of the kidney in cardio-renal syndrome: renal venous hypertension and congestive kidney failure
verfasst von
Pierpaolo Di Nicolò
Publikationsdatum
31.01.2018
Verlag
Springer US
Erschienen in
Heart Failure Reviews / Ausgabe 2/2018
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-018-9673-4

Weitere Artikel der Ausgabe 2/2018

Heart Failure Reviews 2/2018 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.